L. Xu

Sedative and hypnotic activities of the ethanol fraction from Fructus Schisandrae in mice and rats

Fang Huang, Yating Xiong, L. Xu et al. · Journal of Ethnopharmacology · 2006 · 79 citations

Psychoactive Drug, Fructus Schisandrae, Ethanol Fraction +7

High epiregulin (<i>EREG</i>) gene expression plus <i>K-ras</i> wild-type (WT) status as predictors of cetuximab benefit in the treatment of advanced colorectal cancer (ACRC): Results from NCIC CTG CO.17—A phase III trial of cetuximab versus best supportive care (BSC)

Derek J. Jonker, Christos S. Karapetis, Christopher Harbison et al. · Journal of Clinical Oncology · 2009 · 39 citations

Immunology, Pathology, Advanced Colorectal Cancer +20

<i>K-Ras</i> mutation (mut), EGFR-related, and exploratory markers as response predictors of cetuximab in first-line advanced NSCLC: Retrospective analyses of the BMS099 trial

Shirin Khambata‐Ford, Christopher Harbison, Donald Woytowitz et al. · Journal of Clinical Oncology · 2009 · 19 citations

Response Predictors, Immunology, Pathology +17

Predictive biomarker discovery and validation for the targeted chemotherapeutic ixabepilone

H. Lee, L. Xu, Shujian Wu et al. · Journal of Clinical Oncology · 2006 · 17 citations

Drug Target, Breast Oncology, Pathology +21

Total polyphenol of <i><scp>A</scp>nemarrhena asphodeloides</i> ameliorates advanced glycation end products‐induced endothelial dysfunction by regulation of <scp>AMP</scp>‐<scp>K</scp>inase (知母多酚通过激活AMP‐激酶来缓解糖基化终末产物引起的内皮损伤)

Qianwen Zhao, Yan Sun, Yu Ji et al. · Journal of Diabetes · 2013 · 10 citations